Mooberry SL, Kingston DGI, Smith AB III, Swanson SM, Wani MC. Special Issue in Honor of Professor Susan Band Horwitz J Nat Prod 2018 Jan;81:449-450.
Pederson PJ, Cai S, Carver, CM, Powell, DR, Risinger AL, Grkovic T, O'Keefe, BR, Cichewicz, RH, Mooberry SL. Triple-negative breast cancer cells exhibit differential sensitivity to cardenolides from Calotropis gigantea. J. Nat. Prod. 2020, Jul 83(7), 2269-2280.
Kil Y-S, Risinger AL, Petersen CL, Mooberry SL, Cichewicz RH. Leucinostatins from Ophiocordyceps spp. and Purpureocillium spp. demonstrate selective antiproliferative effects in cells representing the luminal androgen receptor subtype of triple negative breast cancer. J Nat Prod. 83, 2010-2024, 2020.
Kil Y-S, Risinger AL, Petersen CL, Liang H, Grkovic T, O’Keefe BR, Mooberry SL, Cichewicz RH. Using the cancer dependency map to identify the mechanism of action of a cytotoxic alkenyl derivative from the fruit of Choerospondias axillaris. J Nat Prod.83, 584-592, 2020.
Kaul R, Risinger AL, Mooberry SL. Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner. Br J Cancer, 121:611-621, 2019.
Grant CV, Carver CM, Hastings SD, Ramachandran K, Muniswamy M, Risinger AL, Beutler JA, Mooberry SL. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. Breast Cancer Res Treat. 2019.
Du L, Risinger AL, Yee, S, Ola, ARB, Zammiello, CL, Cichewicz RH, Mooberry, SL. Identification of C-6 as a new site for linker conjugation to the taccalonolide microtubule stabilizers. J Nat. Prod. 82(3):583-588, 2019.
Ola ARB, Risinger AL, Du L, Zammiello CL, Peng J, Cichewicz RH, Mooberry SL. Taccalonolide microtubule stabilizers generated using semisynthesis define the effects of mono acyloxy moieties at C-7 or C-15 and disubstitutions at C-7 and C-25 J Nat Prod 2018 Jan;.
Dybdal-Hargreaves NF, Risinger AL, Mooberry SL. Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin Oncotarget 2018 Jan;9:5545-5561.
Robles AJ, McCowen S, Cai S, Glassman M, Ruiz F, Cichewicz RH, McHardy SF, Mooberry SL. Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells. J. Med. Chem 60, 9275-9289, 2017.
Gupton JT, Yeudall S, Telang N, Hoerrner M, Huff E, Crawford E, Lounsbury K, Kimmel M, Curry W, Harrison A, Juekun W, Shimozono A, Ortolani J, Lescalleet K, Patteson J, Moore-Stoll V, Rohena CC, Mooberry SL, Obaidullah AJ, Kellogg GE, Sikorski JA. Ortho group activation of a bromopyrrole ester in Suzuki-Miyaura cross-coupling reactions: Application to the synthesis of new microtubule depolymerizing agents with potent cytotoxic activities. Bioorg Med Chem. 25:3206-3214, 2017.
Jans PE, Mfuh AM, Arman HD, Shaffer CV, Larionov OV, Mooberry SL. Cytotoxicity and mechanism of action of the marine-derived fungal metabolite trichodermamide B and synthetic analogues. J Nat Prod. 80:676-683, 2017.
Rohena CC, Risinger AL, Devambatla RK, Dybdal-Hargreaves NF, Kaul R, Choudhary S, Gangjee A, Mooberry SL. Janus compounds, 5-chloro-N⁴-methyl-N⁴-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, cause both microtubule depolymerizing and stabilizing effects. 2016 Molecules 21: E1661.
Robles AJ, Du L, Cichewicz RH, Mooberry SL. Maximiscin induces DNA damage, activates DNA damage response pathways, and has selective cytotoxic activity against a subtype of triple-negative breast cancer. J Nat Prod.79: 1822-1827, 2016.
Robles AJ, Cai S, Cichewicz RH, Mooberry SL. Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer. Breast Cancer Res Treat. 157:475-488, 2016
Kaul R, Risinger AL, Mooberry SL. Microtubule-Targeting Drugs: More than Antimitotics. J Nat Prod. 82:680-685, 2019.
Dybdal-Hargreaves NF, Risinger AL, Mooberry SL. Eribulin Mesylate: mechanism of action of a unique microtubule-targeting agent Clinical Cancer Research 2015 Apr;21:2445-2452.
Rohena CC and Mooberry SL. Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities. Natural Product Reports, 31:335-355, 2014.